The estimated Net Worth of Roy T Eddleman is at least $71.3 Million dollars as of 9 August 2018. Roy Eddleman owns over 116,073 units of Repligen stock worth over $53,058,000 and over the last 7 years Roy sold RGEN stock worth over $18,280,242.
Roy has made over 4 trades of the Repligen stock since 2018, according to the Form 4 filled with the SEC. Most recently Roy sold 116,073 units of RGEN stock worth $5,760,703 on 9 August 2018.
The largest trade Roy's ever made was selling 120,000 units of Repligen stock on 8 May 2018 worth over $4,874,400. On average, Roy trades about 58,407 units every 13 days since 2017. As of 9 August 2018 Roy still owns at least 370,000 units of Repligen stock.
You can see the complete history of Roy Eddleman stock trades at the bottom of the page.
Roy's mailing address filed with the SEC is 1801 Century Park E, Los Angeles, CA 90067, USA.
Over the last 22 years, insiders at Repligen have traded over $118,224,292 worth of Repligen stock and bought 160,440 units worth $1,459,521 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Glenn P Muir, and Walter C Herlihy. On average, Repligen executives and independent directors trade stock every 33 days with the average trade being worth of $3,015,702. The most recent stock trade was executed by Ralf Kuriyel on 2 August 2024, trading 7,148 units of RGEN stock currently worth $1,139,034.
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opus™ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen’s corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.
Repligen executives and other stock owners filed with the SEC include: